Fucoidan Derived from Fucus vesiculosus Inhibits the Development of Human Ovarian Cancer via the Disturbance of Calcium Homeostasis, Endoplasmic Reticulum Stress, and Angiogenesis

Hyocheol Bae, Jin Young Lee, Changwon Yang, Gwonhwa Song, Whasun Lim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Marine organisms are sources of several natural compounds with potential clinical use. However, only a few marine-based pharmaceuticals have been approved for use due to limited knowledge on their biological activities. Here, we identified the functional role of fucoidan extracted from Fucus vesiculosus on ovarian cancer. Fucoidan increased the death of ES-2 and OV-90 cells, through a reduction in proliferation, cell cycle arrest, releases of cytochrome c, reactive oxygen species (ROS) generation, and endoplasmic reticulum (ER) stress. Additionally, fucoidan increased the concentration of cytosolic and mitochondrial calcium in both cells. The decrease of cell proliferation was controlled by the inactivation of PI3K and MAPK signaling cascades in ES-2 and OV-90 cells. In a toxicity assay with normal zebrafish larvae, fucoidan did not induce toxicity, cardiotoxicity, development, kinesis, and apoptosis at different concentrations. However, it disrupted tumor formation and vascular development in a zebrafish xenograft model and angiogenesis transgenic (Tg, fli1-eGFP) model, respectively. Collectively, the results indicate that fucoidan may be a novel pharmaceutical for the management of human ovarian cancer.

Original languageEnglish
JournalMarine drugs
Volume18
Issue number1
DOIs
Publication statusPublished - 2020 Jan 9

Fingerprint

Fucus
Endoplasmic Reticulum Stress
Human Development
Ovarian Neoplasms
Homeostasis
Calcium
Zebrafish
Kinesis
Aquatic Organisms
Cell Cycle Checkpoints
Cytochromes c
Phosphatidylinositol 3-Kinases
Heterografts
Pharmaceutical Preparations
Larva
Blood Vessels
Reactive Oxygen Species
Cell Proliferation
fucoidan
Apoptosis

Keywords

  • angiogenesis
  • calcium homeostasis
  • fucoidan
  • marine drug
  • ovarian cancer

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Fucoidan Derived from Fucus vesiculosus Inhibits the Development of Human Ovarian Cancer via the Disturbance of Calcium Homeostasis, Endoplasmic Reticulum Stress, and Angiogenesis. / Bae, Hyocheol; Lee, Jin Young; Yang, Changwon; Song, Gwonhwa; Lim, Whasun.

In: Marine drugs, Vol. 18, No. 1, 09.01.2020.

Research output: Contribution to journalArticle

@article{44792608459e4e2c801f74a6fc436f27,
title = "Fucoidan Derived from Fucus vesiculosus Inhibits the Development of Human Ovarian Cancer via the Disturbance of Calcium Homeostasis, Endoplasmic Reticulum Stress, and Angiogenesis",
abstract = "Marine organisms are sources of several natural compounds with potential clinical use. However, only a few marine-based pharmaceuticals have been approved for use due to limited knowledge on their biological activities. Here, we identified the functional role of fucoidan extracted from Fucus vesiculosus on ovarian cancer. Fucoidan increased the death of ES-2 and OV-90 cells, through a reduction in proliferation, cell cycle arrest, releases of cytochrome c, reactive oxygen species (ROS) generation, and endoplasmic reticulum (ER) stress. Additionally, fucoidan increased the concentration of cytosolic and mitochondrial calcium in both cells. The decrease of cell proliferation was controlled by the inactivation of PI3K and MAPK signaling cascades in ES-2 and OV-90 cells. In a toxicity assay with normal zebrafish larvae, fucoidan did not induce toxicity, cardiotoxicity, development, kinesis, and apoptosis at different concentrations. However, it disrupted tumor formation and vascular development in a zebrafish xenograft model and angiogenesis transgenic (Tg, fli1-eGFP) model, respectively. Collectively, the results indicate that fucoidan may be a novel pharmaceutical for the management of human ovarian cancer.",
keywords = "angiogenesis, calcium homeostasis, fucoidan, marine drug, ovarian cancer",
author = "Hyocheol Bae and Lee, {Jin Young} and Changwon Yang and Gwonhwa Song and Whasun Lim",
year = "2020",
month = "1",
day = "9",
doi = "10.3390/md18010045",
language = "English",
volume = "18",
journal = "Marine Drugs",
issn = "1660-3397",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - Fucoidan Derived from Fucus vesiculosus Inhibits the Development of Human Ovarian Cancer via the Disturbance of Calcium Homeostasis, Endoplasmic Reticulum Stress, and Angiogenesis

AU - Bae, Hyocheol

AU - Lee, Jin Young

AU - Yang, Changwon

AU - Song, Gwonhwa

AU - Lim, Whasun

PY - 2020/1/9

Y1 - 2020/1/9

N2 - Marine organisms are sources of several natural compounds with potential clinical use. However, only a few marine-based pharmaceuticals have been approved for use due to limited knowledge on their biological activities. Here, we identified the functional role of fucoidan extracted from Fucus vesiculosus on ovarian cancer. Fucoidan increased the death of ES-2 and OV-90 cells, through a reduction in proliferation, cell cycle arrest, releases of cytochrome c, reactive oxygen species (ROS) generation, and endoplasmic reticulum (ER) stress. Additionally, fucoidan increased the concentration of cytosolic and mitochondrial calcium in both cells. The decrease of cell proliferation was controlled by the inactivation of PI3K and MAPK signaling cascades in ES-2 and OV-90 cells. In a toxicity assay with normal zebrafish larvae, fucoidan did not induce toxicity, cardiotoxicity, development, kinesis, and apoptosis at different concentrations. However, it disrupted tumor formation and vascular development in a zebrafish xenograft model and angiogenesis transgenic (Tg, fli1-eGFP) model, respectively. Collectively, the results indicate that fucoidan may be a novel pharmaceutical for the management of human ovarian cancer.

AB - Marine organisms are sources of several natural compounds with potential clinical use. However, only a few marine-based pharmaceuticals have been approved for use due to limited knowledge on their biological activities. Here, we identified the functional role of fucoidan extracted from Fucus vesiculosus on ovarian cancer. Fucoidan increased the death of ES-2 and OV-90 cells, through a reduction in proliferation, cell cycle arrest, releases of cytochrome c, reactive oxygen species (ROS) generation, and endoplasmic reticulum (ER) stress. Additionally, fucoidan increased the concentration of cytosolic and mitochondrial calcium in both cells. The decrease of cell proliferation was controlled by the inactivation of PI3K and MAPK signaling cascades in ES-2 and OV-90 cells. In a toxicity assay with normal zebrafish larvae, fucoidan did not induce toxicity, cardiotoxicity, development, kinesis, and apoptosis at different concentrations. However, it disrupted tumor formation and vascular development in a zebrafish xenograft model and angiogenesis transgenic (Tg, fli1-eGFP) model, respectively. Collectively, the results indicate that fucoidan may be a novel pharmaceutical for the management of human ovarian cancer.

KW - angiogenesis

KW - calcium homeostasis

KW - fucoidan

KW - marine drug

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85077898626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077898626&partnerID=8YFLogxK

U2 - 10.3390/md18010045

DO - 10.3390/md18010045

M3 - Article

C2 - 31936539

AN - SCOPUS:85077898626

VL - 18

JO - Marine Drugs

JF - Marine Drugs

SN - 1660-3397

IS - 1

ER -